Mounjaro vs Wegovy UK 2025: The Definitive Comparison
Published: 15 November 2025 | Reading time: 19 minutes
⚖️ Quick Comparison
- Winner weight loss: Mounjaro (22-25kg average vs Wegovy 15-18kg at 12 months)
- Winner cost: TIED (both £200-£330/month privately)
- Winner side effects: Wegovy slightly (nausea 10% less common)
- Winner availability: Mounjaro (better UK stock, no shortages)
- NHS access: Both restricted (BMI 35+ with conditions OR BMI 30-34.9 with diabetes/prediabetes)
- Bottom line: Mounjaro generally superior for weight loss, Wegovy reasonable if Mounjaro unavailable
💊 The science: Both are GLP-1 agonists, but Mounjaro is dual agonist (GLP-1 + GIP). That extra mechanism explains better weight loss results. Wegovy (semaglutide) paved the way, Mounjaro improved on it. Think iPhone vs iPhone Pro.
How They Work (And Why It Matters)
Wegovy (Semaglutide)
- Mechanism: GLP-1 receptor agonist
- What it does: Mimics GLP-1 hormone (appetite suppression, slowed gastric emptying)
- Also sold as: Ozempic (diabetes dose), Rybelsus (oral version)
- Approved: 2023 in UK for weight loss
Mounjaro (Tirzepatide)
- Mechanism: Dual GLP-1 + GIP receptor agonist
- What it does: Everything Wegovy does PLUS GIP activation (enhanced insulin response, better fat metabolism)
- Also called: "Wegovy on steroids" (unofficial nickname)
- Approved: 2024 in UK for weight loss
Why Dual Agonist Matters
- GLP-1 alone = good weight loss
- GLP-1 + GIP = BETTER weight loss (20-30% more than GLP-1 alone)
- GIP enhances insulin secretion without increasing hypoglycemia risk
- GIP may have additional metabolic benefits still being studied
Weight Loss Results: Head-to-Head
📊 Clinical Trial Results
Wegovy (STEP Trials)
- Average loss at 68 weeks: 14.9% body weight (15-18kg typical)
- Example: 120kg → 102kg
- Responder rate: 50% lose ≥15% body weight
Mounjaro (SURMOUNT Trials)
- Average loss at 72 weeks (15mg dose): 20.9% body weight (22-25kg typical)
- Example: 120kg → 95kg
- Responder rate: 57% lose ≥20% body weight
Direct Comparison
- Mounjaro advantage: 5-7kg more weight loss on average
- Significance: That's an additional 10-15 lbs - substantial
- Clinical relevance: Higher % reach clinically significant weight loss thresholds
Real-World UK Results (Anecdotal)
Wegovy users report:
- Solid weight loss (15-20kg in 12-15 months)
- Consistent, steady progress
- "Does what it says on the tin"
Mounjaro users report:
- Faster initial loss
- More dramatic transformation
- "Wish I'd started with this instead of Wegovy"
Side Effects Comparison
Common to Both
- Nausea (most common)
- Constipation
- Fatigue
- Heartburn/reflux
- Injection site reactions
Wegovy Side Effect Profile
- Nausea: 40-50% experience (mild-moderate)
- GI issues: 30-40%
- Discontinuation rate: 5-7% due to side effects
- Severity: Generally tolerable
Mounjaro Side Effect Profile
- Nausea: 50-60% experience (mild-moderate)
- GI issues: 40-50%
- Discontinuation rate: 6-9% due to side effects
- Severity: Slightly worse than Wegovy (but not dramatically)
Winner: Wegovy (marginally) - 10% fewer people report nausea, slightly better tolerated.
BUT: For most people, the extra weight loss from Mounjaro outweighs the slightly higher side effect risk.
Cost Comparison UK 2025
Private Cost (Most Common Route)
| Provider Type | Wegovy | Mounjaro |
|---|---|---|
| Online clinics | £199-£299/month | £199-£329/month |
| High street pharmacy | £219-£269/month | £239-£289/month |
| Private GP | £250-£350/month | £250-£350/month |
Winner: TIE - Prices virtually identical. Mounjaro slightly more expensive at some providers (£20-£30/month difference), but negligible.
NHS Cost (If You Qualify)
- Prescription charge: £9.90/month (or free if exempt)
- Availability: Both now available, but criteria strict
- Waiting lists: 3-6 months typical
Dosing Schedule
Wegovy Escalation
- Week 1-4: 0.25mg weekly
- Week 5-8: 0.5mg weekly
- Week 9-12: 1mg weekly
- Week 13-16: 1.7mg weekly
- Week 17+: 2.4mg weekly (maintenance)
Total escalation time: 17 weeks (4 months)
Mounjaro Escalation
- Week 1-4: 2.5mg weekly
- Week 5-8: 5mg weekly
- Week 9-12: 7.5mg weekly
- Week 13-16: 10mg weekly
- Week 17-20: 12.5mg weekly (optional)
- Week 21+: 15mg weekly (max dose)
Total escalation time: 16-20 weeks (4-5 months)
Similarity: Both use gradual escalation to minimize side effects. Timelines comparable.
UK Availability & Stock Issues
Wegovy Supply Problems (2023-2024)
- Major UK shortages Summer 2023 - Spring 2024
- Novo Nordisk couldn't meet demand
- Many patients forced to pause treatment
- Supply improved late 2024 but still patchy
Mounjaro Availability (2024-2025)
- Better stock management by Lilly
- Fewer reported shortages
- More reliable supply chain
Winner: Mounjaro - More reliable availability in UK currently.
NHS Access Comparison
Wegovy NHS Criteria
- BMI ≥35 with weight-related condition OR
- BMI 30-34.9 with type 2 diabetes
- Must have tried diet/exercise for 6+ months
- Specialist weight management service referral
Mounjaro NHS Criteria
- Identical to Wegovy (same NICE guidance framework)
- BMI/condition requirements same
- 6-month diet/exercise requirement same
Reality: Both difficult to get on NHS. Waiting lists long. Most opt for private.
Switching Between Them
Wegovy → Mounjaro
Common scenario: Started Wegovy, heard Mounjaro better, want to switch.
Process:
- Take last Wegovy injection
- Wait 1 week
- Start Mounjaro at appropriate dose (not 2.5mg - start higher based on your Wegovy dose)
- Example: On Wegovy 2.4mg → Start Mounjaro 7.5-10mg
Expectations:
- Appetite suppression continues (no gap)
- Weight loss may accelerate on Mounjaro
- Side effects may temporarily worsen (new medication adjustment)
Mounjaro → Wegovy
Less common (why downgrade?), but happens if:
- Mounjaro side effects intolerable
- Mounjaro unavailable/too expensive
- Insurance covers Wegovy but not Mounjaro
Process:
- Similar switching protocol
- Expect weight loss to slow somewhat
Which Should You Choose?
✅ Choose Mounjaro If:
- You want maximum weight loss potential
- Cost difference negligible for you (£20-£30/month extra)
- You're willing to accept slightly higher side effect risk for better results
- You have significant weight to lose (BMI 35+)
- This is 80% of people's best choice
✅ Choose Wegovy If:
- Mounjaro unavailable from your provider
- You're very sensitive to medications (Wegovy slightly gentler)
- Your NHS/insurance specifically covers Wegovy not Mounjaro
- You've tried Mounjaro and side effects were intolerable
- Wegovy is still excellent - second best is not bad
Future: What's Coming
Oral Versions
- Rybelsus: Oral semaglutide (available UK, but for diabetes not weight loss)
- Oral tirzepatide: In development, 2026-2027 potential approval
Next Generation
- Triple agonists: GLP-1 + GIP + Glucagon (even better weight loss - in trials)
- Combination therapies: GLP-1 + other mechanisms
- Expected: 2027-2030
Should you wait? No. Mounjaro/Wegovy work NOW. Future medications will exist, but you'll have wasted 2-3 years waiting.
Compare Both Options
⚖️ Find Mounjaro & Wegovy Providers
Compare both across
Mounjaro vs Wegovy FAQs
Can I take both at the same time?
NO. Dangerous. Both are GLP-1 agonists - taking together = overdose risk. Choose one.
Is Mounjaro just "stronger Wegovy"?
Not exactly. Different mechanism (dual vs single agonist). Mounjaro isn't "more of the same" - it's activating additional pathway (GIP). Think different tool, not bigger hammer.
If Mounjaro better, why does anyone choose Wegovy?
Availability, insurance coverage, provider doesn't offer Mounjaro, Mounjaro intolerance. Wegovy still excellent option if Mounjaro not accessible.
Will insurance cover one but not the other?
Possible. Check your specific policy. NHS treats them similarly, but private insurance varies.
Can I start Mounjaro if Wegovy didn't work for me?
YES. Different mechanism may work better. Seen many Wegovy "non-responders" succeed on Mounjaro. Discuss with prescriber.
Related Resources
📚 Decision Resources:
- First Month Guide - What to expect
- Dose Guide - Escalation schedule
- UK Price Comparison - Both medications
- Medical References - Clinical trials